智力障碍或痴呆症患者的鼻:系统性审查
Gemma Testerink1,2, Annet Ten Brug1, Gerdine Douma1
1Academic Collaborative Centre for Profound Intellectual and Multiple Disabilities, Department of Pedagogical and Educational Sciences, Faculty of Behavioural and Social Sciences, University of Groningen, Grote Rozenstraat 38, 9712 TJ Groningen, The Netherlands.
International journal of nursing studies advances
|May 15, 2024
概括
涉及多感官刺激的snoezelen疗法对智力障碍或痴呆症患者具有多种影响,主要影响心理健康. 然而,对应用细节的不一致报告阻碍了对其有效性的分析.
科学领域:
- 康复医学 康复医学 康复医学
- 智力障碍 智力障碍 智力障碍
- 老年医学 老年医学
背景情况:
- 鼻是一种在适应环境中使用多感官刺激的治疗方法,最初用于严重智力障碍的人.
- 它的应用已经扩大到不同的群体和目的,导致了变化.
- 这种变异性使理解Snoezelen的应用特征及其与观察到的效果的关系变得复杂.
研究的目的:
- 对智力障碍或痴呆症患者的Snoezelen干预措施的应用和影响进行审查.
- 分析Snoezelen特定应用特征及其结果之间的相关性.
主要方法:
- 进行了系统审查,搜索了五个数据库,以寻找适应环境中的Snoezelen研究.
- 混合方法评估工具评估了研究质量.
- 应用特征 (刺激,环境,支持) 和效应被提取并使用AAIDD模型进行分类.
主要成果:
- 包括62项涉及智力障碍 (n=30) 和痴呆症 (n=32) 的研究.
- 申请细节经常缺失,尽管在所有研究中都有一个支持人员.
- 在所有人类功能维度中观察到积极影响,心理健康改善 (减少具有挑战性的行为,更好的情绪) 是最常见的 (61.3%).
结论:
- 大多数研究都缺乏关于Snoezelen应用特征的足够细节.
- 报告的效应多样化,主要在心理健康方面,但无法确定与应用特点的直接关系.
- 未来的研究必须仔细记录应用细节,以澄清Snoezelen干预及其结果之间的联系.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Intellectual Disability
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...